This would aid the volume of plasma collected per center, but also reduce blood donor screening. We also think CSL benefits from superior fractionation expertise and quality processes, enabling ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business. Australia-based CSL, which runs a network of ...